用于拉莫特里金分子印制药载体的物理化学参数的设计,合成和表征
Monika Sobiech1, Sandile M Khamanga2, Karol Synoradzki3
1Department of Organic and Physical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.
International journal of molecular sciences
|May 11, 2024
概括
研究人员开发了一种磁性分子印记聚合物 (MIP) 用于拉莫特林药物输送. 优化的磁性MIP显示了受控释放,这表明有可能进行鼻腔拉莫特里金的注射.
科学领域:
- 材料科学 材料科学 材料科学
- 聚合物化学 聚合物化学
- 纳米技术 纳米技术
背景情况:
- 拉莫特里金是一种抗药物.
- 药物输送系统对于有效的治疗结果至关重要.
- 磁性分子印记聚合物提供有针对性的交付潜力.
研究的目的:
- 开发和优化用于lamotrigine的磁性分子印记聚合物 (MIP).
- 评估磁性MIP的药物载荷能力和释放特性.
- 评估磁性MIP在拉莫特里金鼻服剂中的潜力.
主要方法:
- 使用吸附研究和理论分析优化磁性聚合物组成.
- 从伊塔康酸和乙烯基甘醇二甲基烯酸盐合成磁性MIP.
- 使用粉末X射线衍射,振动样本磁力测量和FTIR光谱学进行表征.
- 在pH 5和8的酸盐缓冲盐溶液中进行的体外药物释放研究.
主要成果:
- 磁性MIP的药物负载能力为3.4±0.9μggg-1.
- 结构特征证实了聚合物的磁性和印记性质.
- 在测试的pH水平下,观察到有控制的药物释放,没有爆发效应.
结论:
- 开发的磁性MIP是lamotrigine药物输送的有希望的候选者.
- 控制释放的特征支持其潜在的鼻腔注射.
- 进一步的研究可能会导致lamotrigine的先进治疗应用.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


